Swedish drug firms band to examine RA
08:58 EDT 7 Aug 2012 | Advanstar News Headlines
Pharmaceutical firm Swedish Orphan Biovitrum (Sobi) will join Affibody AB, a Swedish biotechnology company, in a research collaboration to develop anti-inflammatory interleukin-1 therapies. Sobi markets the novel recombinant IL-1 inhibitor kn..
Original Article: Swedish drug firms band to examine RA
More From BioPortfolio on "Swedish drug firms band to examine RA"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
